236 related articles for article (PubMed ID: 32627966)
1. Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5
Nakamura K; Taniguchi T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Trojanowska M; Fujiu K; Nagai R; Sato S; Asano Y
Arthritis Rheumatol; 2020 Dec; 72(12):2136-2146. PubMed ID: 32627966
[TBL] [Abstract][Full Text] [Related]
2. Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.
Asano Y
Med Mol Morphol; 2015 Sep; 48(3):123-8. PubMed ID: 25986681
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
[TBL] [Abstract][Full Text] [Related]
4. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding ability.
Akamata K; Asano Y; Yamashita T; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
Arthritis Rheumatol; 2015 May; 67(5):1335-44. PubMed ID: 25707716
[TBL] [Abstract][Full Text] [Related]
6. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
Asano Y
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in animal models of systemic sclerosis.
Asano Y
J Dermatol; 2016 Jan; 43(1):19-28. PubMed ID: 26782003
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.
Asano Y; Stawski L; Hant F; Highland K; Silver R; Szalai G; Watson DK; Trojanowska M
Am J Pathol; 2010 Apr; 176(4):1983-98. PubMed ID: 20228226
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
[TBL] [Abstract][Full Text] [Related]
10. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis.
Yamaguchi Y; Okazaki Y; Seta N; Satoh T; Takahashi K; Ikezawa Z; Kuwana M
Arthritis Res Ther; 2010; 12(6):R205. PubMed ID: 21050433
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.
Akamata K; Asano Y; Taniguchi T; Yamashita T; Saigusa R; Nakamura K; Noda S; Aozasa N; Toyama T; Takahashi T; Ichimura Y; Sumida H; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2015 Jul; 54(7):1308-16. PubMed ID: 25539827
[TBL] [Abstract][Full Text] [Related]
12. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
[TBL] [Abstract][Full Text] [Related]
15. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow endothelial progenitors are defective in systemic sclerosis.
Del Papa N; Quirici N; Soligo D; Scavullo C; Cortiana M; Borsotti C; Maglione W; Comina DP; Vitali C; Fraticelli P; Gabrielli A; Cortelezzi A; Lambertenghi-Deliliers G
Arthritis Rheum; 2006 Aug; 54(8):2605-15. PubMed ID: 16868984
[TBL] [Abstract][Full Text] [Related]
17. A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
Exp Dermatol; 2015 Feb; 24(2):127-32. PubMed ID: 25421497
[TBL] [Abstract][Full Text] [Related]
18. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.
Trojanowska M
Nat Rev Rheumatol; 2010 Aug; 6(8):453-60. PubMed ID: 20585340
[TBL] [Abstract][Full Text] [Related]
20. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
